Your browser doesn't support javascript.
loading
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma.
Cichocki, Frank; Bjordahl, Ryan; Goodridge, Jodie P; Mahmood, Sajid; Gaidarova, Svetlana; Abujarour, Ramzey; Davis, Zachary B; Merino, Aimee; Tuininga, Katie; Wang, Hongbo; Kumar, Akhilesh; Groff, Brian; Witty, Alec; Bonello, Greg; Huffman, Janel; Dailey, Thomas; Lee, Tom T; Malmberg, Karl-Johan; Walcheck, Bruce; Höpken, Uta; Rehm, Armin; Valamehr, Bahram; Miller, Jeffrey S.
Affiliation
  • Cichocki F; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA.
  • Bjordahl R; Fate Therapeutics, San Diego, CA, 92121, USA.
  • Goodridge JP; Fate Therapeutics, San Diego, CA, 92121, USA.
  • Mahmood S; Fate Therapeutics, San Diego, CA, 92121, USA.
  • Gaidarova S; Fate Therapeutics, San Diego, CA, 92121, USA.
  • Abujarour R; Fate Therapeutics, San Diego, CA, 92121, USA.
  • Davis ZB; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA.
  • Merino A; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA.
  • Tuininga K; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA.
  • Wang H; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA.
  • Kumar A; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA.
  • Groff B; Fate Therapeutics, San Diego, CA, 92121, USA.
  • Witty A; Fate Therapeutics, San Diego, CA, 92121, USA.
  • Bonello G; Fate Therapeutics, San Diego, CA, 92121, USA.
  • Huffman J; Fate Therapeutics, San Diego, CA, 92121, USA.
  • Dailey T; Fate Therapeutics, San Diego, CA, 92121, USA.
  • Lee TT; Fate Therapeutics, San Diego, CA, 92121, USA.
  • Malmberg KJ; Oslo University Hospital, Oslo, Norway.
  • Walcheck B; University of Minnesota, Department of Veterinary and Biomedical Sciences, St. Paul, MN, 55108, USA.
  • Höpken U; Max-Delbrück-Center for Molecular Medicine, MDC, Berlin, Germany.
  • Rehm A; Max-Delbrück-Center for Molecular Medicine, MDC, Berlin, Germany.
  • Valamehr B; Fate Therapeutics, San Diego, CA, 92121, USA. bob.valamehr@fatetherapeutics.com.
  • Miller JS; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA. mille011@umn.edu.
Nat Commun ; 13(1): 7341, 2022 11 29.
Article in En | MEDLINE | ID: mdl-36446823
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2022 Type: Article Affiliation country: United States